But I think the profit has gotten way out of control in many cases. I want to make sure the potential for profit is truly incentivizing innovation, not just lining investors' pockets.
On the recordDecember 12, 2017
Source
congress.govEditor's note · Context
DeGette critiques excessive profits in the pharmaceutical industry and calls for genuine innovation incentives.
Share
More from Diana DeGette
Mar 28, 2023
I was pleased to see that, as part of these bills, there was an increase in funding for inspector generals' offices, for the most part, and to do this work, because I think it is important work.
Jun 9, 2026
Far and away it’s Donald Trump. Denverites are alarmed by the damage this administration is doing every day to our country, our democracy, and our economy.
Mar 28, 2023
It is a little embarrassing for someone like me, who is trying to tell colleagues around the world that we need to have robust oversight, that the U.S. Congress is actually having an oversight hearing that is so vague that you can't…





